Loading...
Delta-Fly Pharma, Inc.
4598.T•JPX
Healthcare
Biotechnology
¥696.00
¥-15.00(-2.11%)
Delta-Fly Pharma, Inc. (4598.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Delta-Fly Pharma, Inc. (4598.T), featuring income statements, balance sheets, and cash flow data.
Revenue Growth
0.00%
Operating Income Growth
-6.66%
↓ 6.66%
Net Income Growth
-7.57%
↓ 7.57%
Operating Cash Flow Growth
1.80%
↑ 1.80%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-341.89%
↓ 341.89%
ROIC
-614.65%
↓ 614.65%
Delta-Fly Pharma, Inc. (4598.T) Income Statement & Financial Overview
Analyze Delta-Fly Pharma, Inc.’s 4598.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $394000.00 | $441000.00 |
| Gross Profit | $0.00 | $0.00 | -$394000.00 | -$441000.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $310.00M | $365.00M | $417.00M | $377.61M |
| SG&A Expenses | $66.00M | $54.00M | $80.00M | $76.46M |
| Operating Expenses | $377.00M | $419.00M | $497.00M | $454.07M |
| Total Costs & Expenses | $377.00M | $419.00M | $497.00M | $454.07M |
| Interest Income | $0.00 | $0.00 | $0.00 | $8000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $250000.00 | $250000.00 | $394000.00 | $1000.00 |
| EBITDA | -$375.75M | -$418.75M | -$499.19M | -$454.07M |
| EBITDA Ratio | ||||
| Operating Income | -$377.00M | -$419.00M | -$497.00M | -$454.07M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$13.00M | $3.00M | -$2.58M | -$1.79M |
| Income Before Tax | -$390.00M | -$416.00M | -$499.58M | -$455.87M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $1.00M | $625000.00 | $626000.00 |
| Net Income | -$390.00M | -$417.00M | -$500.00M | -$456.49M |
| Net Income Ratio | ||||
| EPS | -$43.20 | -$50.67 | -$60.76 | -$55.52 |
| Diluted EPS | -$43.20 | -$50.67 | -$60.76 | -$55.52 |
| Weighted Avg Shares Outstanding | $9.03M | $8.23M | $8.23M | $8.22M |
| Weighted Avg Shares Outstanding (Diluted) | $9.03M | $8.23M | $8.23M | $8.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan